Industrie Biomediche Insubri
IBI SA is an innovative Swiss biomedical company focused on research, development, and production of medical devices for tissue engineering and regenerative medicine, including substitutes, grafts, 3D matrices, and 2D scaffolds. The company emphasizes advanced tissue engineering technology and collaborates internationally on innovative projects to support bone regeneration and other medical applications.
Industries
Nr. of Employees
small (1-50)
Industrie Biomediche Insubri
via Cantonale 67, CH-6805 Mezzovico-Vira, Switzerland
Patents
Products
Porous bone substitute scaffolds for dental reconstructive surgery
Porous xenohybrid bone scaffolds designed for bone regeneration and augmentation in oral and maxillofacial procedures; manufactured with polymer coatings and collagen fragments to support cell attachment and mechanical fixation.
Porous bone substitute scaffolds for orthopaedic and trauma reconstruction
Porous xenohybrid scaffolds and block formats engineered to provide load-bearing structure and support bone regeneration in orthopaedic, trauma and oncological reconstructive surgeries.
Peptide-functionalized next-generation bone grafts
Scaffolds functionalized with synthetic osteoinductive peptides designed to improve cell recruitment, differentiation and mineral apposition for enhanced bone regeneration.
Lyosecretome-loaded scaffolds
Scaffolds combined with lyophilized mesenchymal stem cell secretome (soluble factors and extracellular vesicles) to provide a pro-regenerative microenvironment and improve in vitro and in vivo osteogenic outcomes.
Veterinary bone graft product
Adaptation of human regenerative bone scaffold technology for veterinary surgical applications, offered through partnership commercialization.
Porous bone substitute scaffolds for dental reconstructive surgery
Porous xenohybrid bone scaffolds designed for bone regeneration and augmentation in oral and maxillofacial procedures; manufactured with polymer coatings and collagen fragments to support cell attachment and mechanical fixation.
Porous bone substitute scaffolds for orthopaedic and trauma reconstruction
Porous xenohybrid scaffolds and block formats engineered to provide load-bearing structure and support bone regeneration in orthopaedic, trauma and oncological reconstructive surgeries.
Peptide-functionalized next-generation bone grafts
Scaffolds functionalized with synthetic osteoinductive peptides designed to improve cell recruitment, differentiation and mineral apposition for enhanced bone regeneration.
Lyosecretome-loaded scaffolds
Scaffolds combined with lyophilized mesenchymal stem cell secretome (soluble factors and extracellular vesicles) to provide a pro-regenerative microenvironment and improve in vitro and in vivo osteogenic outcomes.
Veterinary bone graft product
Adaptation of human regenerative bone scaffold technology for veterinary surgical applications, offered through partnership commercialization.
Services
Design and production of custom-shaped bone grafts from clinical imaging data; service conforms with EU Medical Device Regulation requirements for custom-made devices.
Collection and analysis of clinical feedback, case reports, patient implant documentation and radiographic monitoring to evaluate long-term implant performance.
E-commerce storefront for direct purchase of bone graft forms for specified national markets.
Management of product registrations and technical documentation to meet regulatory requirements across multiple jurisdictions.
Design and production of custom-shaped bone grafts from clinical imaging data; service conforms with EU Medical Device Regulation requirements for custom-made devices.
Collection and analysis of clinical feedback, case reports, patient implant documentation and radiographic monitoring to evaluate long-term implant performance.
E-commerce storefront for direct purchase of bone graft forms for specified national markets.
Management of product registrations and technical documentation to meet regulatory requirements across multiple jurisdictions.
Expertise Areas
- Bone tissue engineering
- Scaffold biomaterials and surface functionalization
- Custom implant design and manufacturing
- Preclinical and in vitro validation for osteogenesis
Key Technologies
- Xenohybrid porous bone scaffolds
- Bioactive polymer surface coatings
- Collagen-fragment surface modification
- Osteoinductive peptides / intrinsically disordered proteins
News & Updates
IBI developed and validated a non-invasive radiographic protocol to monitor the long-term performance of SmartBone® in bone regeneration.
The custom-made bone graft service received MDR certification, ensuring compliance with European health and safety standards.
IBI's innovative materials for bone repair in pediatric oncology are featured in a scientific article.
An article published in Implantbook 2021 highlighting the innovative features of SmartBone®.
MDR Certification for SmartBone® On Demand™
Certification of the custom-made bone graft service according to the European Medical Device Regulation 2017/745.
Development of a non-invasive radiographic protocol for bone density assessment
Validated method for monitoring long-term performance of bone grafts in vivo.
IBI developed and validated a non-invasive radiographic protocol to monitor the long-term performance of SmartBone® in bone regeneration.
The custom-made bone graft service received MDR certification, ensuring compliance with European health and safety standards.
IBI's innovative materials for bone repair in pediatric oncology are featured in a scientific article.
An article published in Implantbook 2021 highlighting the innovative features of SmartBone®.
MDR Certification for SmartBone® On Demand™
Certification of the custom-made bone graft service according to the European Medical Device Regulation 2017/745.
Development of a non-invasive radiographic protocol for bone density assessment
Validated method for monitoring long-term performance of bone grafts in vivo.